1. Home
  2. XENE vs TPC Comparison

XENE vs TPC Comparison

Compare XENE & TPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • TPC
  • Stock Information
  • Founded
  • XENE 1996
  • TPC 1894
  • Country
  • XENE Canada
  • TPC United States
  • Employees
  • XENE N/A
  • TPC N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • TPC General Bldg Contractors - Nonresidential Bldgs
  • Sector
  • XENE Health Care
  • TPC Consumer Discretionary
  • Exchange
  • XENE Nasdaq
  • TPC Nasdaq
  • Market Cap
  • XENE 2.4B
  • TPC 2.5B
  • IPO Year
  • XENE 2014
  • TPC N/A
  • Fundamental
  • Price
  • XENE $39.21
  • TPC $62.62
  • Analyst Decision
  • XENE Strong Buy
  • TPC Strong Buy
  • Analyst Count
  • XENE 11
  • TPC 3
  • Target Price
  • XENE $52.73
  • TPC $60.67
  • AVG Volume (30 Days)
  • XENE 833.8K
  • TPC 633.0K
  • Earning Date
  • XENE 08-11-2025
  • TPC 11-05-2025
  • Dividend Yield
  • XENE N/A
  • TPC N/A
  • EPS Growth
  • XENE N/A
  • TPC N/A
  • EPS
  • XENE N/A
  • TPC N/A
  • Revenue
  • XENE $7,500,000.00
  • TPC $4,770,779,000.00
  • Revenue This Year
  • XENE N/A
  • TPC $23.30
  • Revenue Next Year
  • XENE $256.34
  • TPC $12.61
  • P/E Ratio
  • XENE N/A
  • TPC N/A
  • Revenue Growth
  • XENE N/A
  • TPC 12.03
  • 52 Week Low
  • XENE $26.74
  • TPC $18.34
  • 52 Week High
  • XENE $46.00
  • TPC $63.96
  • Technical
  • Relative Strength Index (RSI)
  • XENE 67.80
  • TPC 75.33
  • Support Level
  • XENE $38.13
  • TPC $56.62
  • Resistance Level
  • XENE $39.84
  • TPC $60.41
  • Average True Range (ATR)
  • XENE 0.99
  • TPC 1.82
  • MACD
  • XENE -0.09
  • TPC 0.05
  • Stochastic Oscillator
  • XENE 77.70
  • TPC 99.72

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About TPC Tutor Perini Corporation

Tutor Perini Corp offers general contracting, construction management, and design-build services to private and public customers. The company constructs and repairs transportation infrastructure, water-treatment facilities, and a wide range of buildings. Tutor Perini has three operating segments: Civil, Building, and Specialty Contractors. A majority of its revenue is generated from the Civil segment, which specializes in public works construction and the replacement and reconstruction of infrastructure. Its civil contracting services include construction and rehabilitation of highways, bridges, tunnels, mass-transit systems, military and other government facilities, and water management and wastewater treatment facilities. Geographically, it derives key revenue from the United States.

Share on Social Networks: